INTRODUCTION AND OBJECTIVES: To optimise complication reporting in patients undergoing cystectomy and urinary diversion (UD) using the Comprehensive Complication Index (CCI). The original CCI ranging from 0 (no complications) to 100 (death) integrates all complications weighted by severity over time in a single formula. However, due to the large number of complications after cystectomy and UD, the CCI may exceed the upper limit.
INTRODUCTION AND OBJECTIVES: To optimise complication reporting in patients undergoing cystectomy and urinary diversion (UD) using the Comprehensive Complication Index (CCI). The original CCI ranging from 0 (no complications) to 100 (death) integrates all complications weighted by severity over time in a single formula. However, due to the large number of complications after cystectomy and UD, the CCI may exceed the upper limit.
METHODS: In an observational single-center cohort, 90d postoperative complications in 1,313 consecutive patients undergoing cystectomy and UD from 2000 to 2017 were evaluated. Prospectively collected complications were graded according to the Clavien-Dindo Classification (CDC). A modified Berne CCI was developed using an exponential function, which transforms the sum of the weights into a value between 0 and 100. The correlation between the Berne and original CCI values was depicted graphically. Finally, original CCI and Berne CCI values for each patient were extracted and compared. Predictive values of CCI scores for mortality or severe complications (CDC IV/V) within 1 year postoperatively were investigated by use of multiple logistic regression analyses.
RESULTS: Overall complication rate was 82%, with CDC grade I-II in 56% and CDC grade IIIa-V in 27% respectively. Applying the original CCI, the upper limit was exceeded in 8 patients, with a maximal value of 119.1 (median 25.7 [interquartile range: 20.9-37.2]). The maximal value of the Berne CCI was 99.4 (21.2 [14.6-39 .3]) for non-death cases. The Berne CCI predicted the onset of death and severe complications between postoperative day 91 and 365 (both P<0.0001), whereas the original CCI was only predictive in interaction with other variables but not alone (P[0.2772 and P[0.0862, respectively) .
CONCLUSIONS: The optimized Berne CCI depicts postoperative morbidity and burden within 90d after cystectomy and UD without exceeding the upper index limit. It is specifically suited for longitudinal assessment of complications after cystectomy and UD taking into consideration every single complication and corresponding treatment. As the Berne CCI well predicted the onset of mortality and severe complications within one year postoperatively, this may allow a better preoperative patient counselling. It therefore warrants consideration for standardized reporting of complications after cystectomy and UD.
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MP26-20 ROBOTIC RADICAL CYSTECTOMY OUTCOMES BEFORE AND AFTER ENHANCED RECOVERY AFTER SURGERY (ERAS) PATHWAY
METHODS: A total of 272 patients (n[76 No ERAS pathway, n[196 ERAS pathway) underwent a RRC with intention to cure from August 2009 to August 2016 as identified from our prospectively collated institutional approved database. Pre-, intra-and postoperative characteristics, oncological outcomes, 90-day complications, recurrence free survival (RFS) and cost variables (adjusted to 2017 USD) were compared on univariate analysis. RFS was calculated by log-rank test and multivariable regression was used to assess the effect of ERAS on significant outcomes identified on univariate analysis.
RESULTS: Patients undergoing RRC without and with ERAS pathway were similar in terms of age (71 v 72yrs), sex, charlsoncormorbidity index, ASA, pathological outcomes, 90-day complication rates (79% v 70%), readmission rates, RFS or total variable cost ($29,909 v $29,484 USD) (p>0.05). (Table 1) The use of intracorporeal diversion was more common during an ERAS pathway (p<0.001).
RRC with ERAS protocol was associated with a reduced LOS (7v5day p<0.001), reduced EBL and need for transfusion postoperatively (p<0.05). On multivariable analysis, after controlling for age, diversion type and Charlson score and p-stage, ERAS remained an independent predictive factor for reduced LOS and need for postoperative transfusion.
CONCLUSIONS: The use of ERAS pathway in RRC is associated with a reduced LOS and need for post-operative transfusion. ERAS pathway does not influence complication rates, readmission rates or total variable cost during RRC. 
